Research
Cellular
The goal of management in T2D patients with significant fibrosis is to slow the progression of liver disease and reduce associated clinical events.
Clinicians should aim to adapt therapies to manage liver disease progression in diabetic patients.
StrongSupportsmedium confidence
Our goal is to provide clinical guidance for adapting drug therapy in the presence of significant fibrosis in order to slow the progression of liver disease and reduce the risk of associated clinical events.
Why this rating
The claim is based on expert consensus and clinical guidance.
Source
Management of patients with type 2 diabetes and MASLD: An overview and joint statement
Yasmina Chouik et al. · Diabetes & Metabolism · 2025
DOI 10.1016/j.diabet.2025.101709
reviewCited 4×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Cellular
- Athletes aiming to reduce fat mass and preserve FFM should consume protein intakes in the range of ∼1.8-2.7 g kg(-1) d(-1).Strong
- A minimum daily protein intake of ≥1.6 g/kg is necessary to observe significant improvements in muscle mass from whey protein supplementation.Strong
- Most athletes ideally need 1.2 to 2.0 grams/kg of body weight/day of protein, preferably split across 3-4 meals.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →